RETRACTED ARTICLE: Efficacy of dexmedetomidine as an adjunct to ropivacaine in bilateral dual-transversus abdominis plane blocks in patients with ovarian cancer who underwent cytoreductive surgery

[1] Prat J(2015)FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication J Gynecol Oncol 26 87-89

[2] Xian W(2019)Meeting report from the 2018 12th biennial ovarian cancer research symposium detection and prevention of ovarian cancer Int J Gynecol Cancer 29 s2-s6

[3] George S(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132

[4] Chen W(2020)Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival J Transl Med 18 134-594

[5] Zheng R(2021)Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Cochrane Database Syst Rev 2 Cd005343-20

[6] Baade PD(2014)Enhanced recovery pathways in gynecologic oncology Gynecol Oncol 135 586-113

[7] Zhang S(2012)Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer PLoS One 7 15-465

[8] Zeng H(2013)The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study Gynecol Oncol 131 112-801

[9] Bray F(2015)TAP block nomenclature Anaesthesia 70 460-301

[10] Dabi Y(2015)Transversus abdominis plane block in robotic gynecologic oncology: a randomized, placebo-controlled trial Gynecol Oncol 136 797-663

[1] Prat J(2015)FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication J Gynecol Oncol 26 87-89

[2] Xian W(2019)Meeting report from the 2018 12th biennial ovarian cancer research symposium detection and prevention of ovarian cancer Int J Gynecol Cancer 29 s2-s6

[3] George S(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132

[4] Chen W(2020)Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival J Transl Med 18 134-594

[5] Zheng R(2021)Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Cochrane Database Syst Rev 2 Cd005343-20

[6] Baade PD(2014)Enhanced recovery pathways in gynecologic oncology Gynecol Oncol 135 586-113

[7] Zhang S(2012)Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer PLoS One 7 15-465

[8] Zeng H(2013)The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study Gynecol Oncol 131 112-801

[9] Bray F(2015)TAP block nomenclature Anaesthesia 70 460-301

[10] Dabi Y(2015)Transversus abdominis plane block in robotic gynecologic oncology: a randomized, placebo-controlled trial Gynecol Oncol 136 797-663